PT3168230T - Mutante de gdf-5 para induzir formação de cartilagem - Google Patents

Mutante de gdf-5 para induzir formação de cartilagem

Info

Publication number
PT3168230T
PT3168230T PT16203435T PT16203435T PT3168230T PT 3168230 T PT3168230 T PT 3168230T PT 16203435 T PT16203435 T PT 16203435T PT 16203435 T PT16203435 T PT 16203435T PT 3168230 T PT3168230 T PT 3168230T
Authority
PT
Portugal
Prior art keywords
gdf
mutant
cartilage formation
inducing cartilage
inducing
Prior art date
Application number
PT16203435T
Other languages
English (en)
Inventor
Plöger Frank
Wagner Florian
Original Assignee
Biopharm Ges Zur Biotechnologischen Entwicklung Von Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopharm Ges Zur Biotechnologischen Entwicklung Von Pharmaka Gmbh filed Critical Biopharm Ges Zur Biotechnologischen Entwicklung Von Pharmaka Gmbh
Publication of PT3168230T publication Critical patent/PT3168230T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/51Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT16203435T 2011-12-05 2012-12-05 Mutante de gdf-5 para induzir formação de cartilagem PT3168230T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11191973.4A EP2602264A1 (en) 2011-12-05 2011-12-05 GDF-5 mutant for inducing cartilage formation

Publications (1)

Publication Number Publication Date
PT3168230T true PT3168230T (pt) 2019-01-30

Family

ID=47278877

Family Applications (2)

Application Number Title Priority Date Filing Date
PT16203435T PT3168230T (pt) 2011-12-05 2012-12-05 Mutante de gdf-5 para induzir formação de cartilagem
PT127950111T PT2788374T (pt) 2011-12-05 2012-12-05 Mutante de gdf-5 para induzir formação de cartilagem

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT127950111T PT2788374T (pt) 2011-12-05 2012-12-05 Mutante de gdf-5 para induzir formação de cartilagem

Country Status (23)

Country Link
US (1) US9718867B2 (pt)
EP (3) EP2602264A1 (pt)
JP (1) JP6185926B2 (pt)
KR (1) KR102067724B1 (pt)
CN (1) CN104039820B (pt)
AU (1) AU2012347305B2 (pt)
BR (1) BR112014013122A2 (pt)
CA (1) CA2856458C (pt)
DK (2) DK2788374T3 (pt)
EA (1) EA028554B1 (pt)
ES (2) ES2630853T3 (pt)
HK (1) HK1198768A1 (pt)
HR (2) HRP20170205T1 (pt)
HU (2) HUE042191T2 (pt)
IN (1) IN2014KN01026A (pt)
LT (2) LT3168230T (pt)
MX (1) MX351809B (pt)
PL (2) PL2788374T3 (pt)
PT (2) PT3168230T (pt)
RS (2) RS55686B1 (pt)
SI (2) SI2788374T1 (pt)
TR (1) TR201901263T4 (pt)
WO (1) WO2013083649A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101639269B1 (ko) 2015-12-02 2016-07-13 주식회사 셀루메드 알칼라인 포스파타아제 어세이를 개선하기 위한 방법
EP4076502A1 (en) 2019-12-18 2022-10-26 Merck Patent GmbH Use of the gdf-5 mutant for the treatment of pain and cartilage destruction
CN111701075A (zh) * 2020-06-24 2020-09-25 亘元(天津)生物医药科技有限公司 一种软骨修复材料、软骨重建生物支架及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439190A1 (en) 1993-01-12 2004-07-21 The Johns Hopkins University School Of Medicine Growth differentiation factor-5
IL110589A0 (en) 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
WO1996014335A1 (en) 1994-11-07 1996-05-17 The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services Cartilage-derived morphogenetic proteins
BR9608019A (pt) 1995-04-19 1999-11-30 Hoechst Japan Uma nova proteína e um processo para a preparação da mesma'
JPH0931098A (ja) 1995-07-24 1997-02-04 Hoechst Japan Ltd 新規なタンパク質hmwヒトmp52
ZA966489B (en) 1995-08-03 1997-02-26 Bioph Biotech Entw Pharm Gmbh New protein human MP52 Arg.
DE19647853A1 (de) 1996-11-19 1998-05-20 Bioph Biotech Entw Pharm Gmbh Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
EP1074620A1 (en) 1999-08-06 2001-02-07 HyGene AG Monomeric protein of the TGF-beta family
JPH11335398A (ja) 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
JP2000119192A (ja) 1998-10-09 2000-04-25 Aventis Pharma Ltd 骨誘導因子アンタゴニスト活性を有する成熟型蛋白質
DE10026713A1 (de) 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
KR100530299B1 (ko) * 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 c 아실라제 및 이를 이용한 7-aca 제조방법
EP1571159A1 (en) 2004-03-04 2005-09-07 Bayerische Julius-Maximilians-Universität Würzburg Mutein of a bone morphogenetic protein and use thereof
EP1698691A1 (en) * 2005-03-04 2006-09-06 Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH Growth factor mutants with improved biological activity
EP1721909A1 (en) 2005-05-10 2006-11-15 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Growth factor mutants with altered biological attributes
JP2007054013A (ja) * 2005-08-26 2007-03-08 Research Institute Of Innovative Technology For The Earth 耐熱性l−スレオニンアルドラ−ゼおよびそれをコードする遺伝子
AU2006314713B2 (en) * 2005-11-18 2011-10-06 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh High activity growth factor mutants
CN103641916A (zh) 2006-03-27 2014-03-19 医学免疫有限公司 Gm-csf受体结合元件
EP1915986A1 (en) 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Lipid growth factor formulations
CN103079585B (zh) 2010-08-20 2015-09-30 惠氏有限责任公司 经设计的成骨蛋白

Also Published As

Publication number Publication date
HRP20190160T8 (hr) 2020-02-07
TR201901263T4 (tr) 2019-02-21
DK2788374T3 (en) 2017-04-10
EP3168230A1 (en) 2017-05-17
WO2013083649A1 (en) 2013-06-13
CA2856458C (en) 2024-03-12
AU2012347305B2 (en) 2016-11-03
ES2630853T3 (es) 2017-08-24
AU2012347305A1 (en) 2014-06-26
EP2788374A1 (en) 2014-10-15
HUE033025T2 (en) 2017-11-28
PL3168230T3 (pl) 2019-06-28
EP2788374B1 (en) 2017-01-04
LT3168230T (lt) 2019-03-12
EA028554B1 (ru) 2017-11-30
PL2788374T3 (pl) 2017-08-31
JP6185926B2 (ja) 2017-08-23
DK3168230T3 (en) 2019-01-14
US20140369978A1 (en) 2014-12-18
EP3168230B1 (en) 2018-12-05
KR102067724B1 (ko) 2020-01-17
RS55686B1 (sr) 2017-07-31
CA2856458A1 (en) 2013-06-13
JP2015504649A (ja) 2015-02-16
EP2602264A1 (en) 2013-06-12
EA201491119A1 (ru) 2014-12-30
SI2788374T1 (sl) 2017-04-26
US9718867B2 (en) 2017-08-01
PT2788374T (pt) 2017-02-15
CN104039820B (zh) 2018-01-09
IN2014KN01026A (pt) 2015-10-09
HRP20190160T1 (hr) 2019-03-22
HK1198768A1 (en) 2015-06-05
LT2788374T (lt) 2017-02-10
SI3168230T1 (sl) 2019-03-29
HRP20170205T1 (hr) 2017-06-16
MX2014006465A (es) 2015-03-20
MX351809B (es) 2017-10-30
HUE042191T2 (hu) 2019-06-28
KR20140100969A (ko) 2014-08-18
ES2708675T3 (es) 2019-04-10
RS58253B1 (sr) 2019-03-29
BR112014013122A2 (pt) 2020-10-27
CN104039820A (zh) 2014-09-10

Similar Documents

Publication Publication Date Title
AP3907A (en) 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
EP2771126A4 (en) FURNACE
GB201121428D0 (en) Controller
GB201121426D0 (en) Controller
GB201105145D0 (en) Controller
AU341795S (en) Paver
TWI560388B (en) Dampferzeugerheizrohrreparaturmittel und reparaturverfahren
EP2748500A4 (en) SUPPORT
GB201110973D0 (en) Bracket
EP2696129A4 (en) LIGHTING APPARATUS
EP2799760A4 (en) ILLUMINATION DEVICE
PL2479398T3 (pl) Wykańczarka albo zasilacz
EP2710865A4 (en) CONTROL UNIT
EP2780631A4 (en) CONNECTABLE LIGHTING DEVICE
EP2799759A4 (en) LIGHTING APPARATUS
HK1198507A1 (en) Controls
HRP20190160T8 (hr) Mutant gdf-5 za indukciju formiranja hrskavice
PL2599920T3 (pl) Wykańczarka
EP2715228A4 (en) ILLUMINATION DEVICE
AU337816S (en) Bracket
GB2496130B (en) Bracket
EP2708797A4 (en) ILLUMINATION DEVICE
GB201103407D0 (en) Genetic association
GB2490658B (en) Lighting apparatus
EP2695868A4 (en) REFRACTORY